Longboard Pharmaceuticals Inc at JMP Securities Life Sciences Conference Transcript
Back to the JMP Life Sciences Conference. It's my pleasure to introduce Longboard Pharmaceuticals with the CEO, Kevin Lind, giving the presentation. Thank you very much for joining us today.
Thank you.
So, thank you to JMP for having us here today. It's been a couple of years since I was last at a JMP Conference. Just a reminder, we'll be making forward-looking statements. Please check our SEC filings for the latest information, and we will be -- our actuals may vary from what we are predicting.
As I said, it's been a couple of years for me since I was at a JMP Conference. We had a great relationship with JMP when we -- I was at Arena. And three years ago, we spun Arena -- Longboard Pharmaceuticals out of Arena.
And the story, the thesis, the strategy behind Longboard is really the story, thesis, strategy behind Arena, which is take some phenomenal molecules that have differentiated PK/PD target engagement, pick the right indications, and move
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |